title: Two recent phase 2 trials of vandetanib in RET-rearranged NSCLC.
authors.affiliation: Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, South Korea. Electronic address: shlee119@skku.edu.
authors.forename: Se-Hoon
authors.initials: SH
authors.lastname: Lee
authors.affiliation: Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, South Korea.
authors.forename: June-Koo
authors.initials: JK
authors.lastname: Lee
mesh_terms: D000970:Antineoplastic Agents; D002289:Carcinoma, Non-Small-Cell Lung; D006801:Humans; D008175:Lung Neoplasms; D051096:Proto-Oncogene Proteins c-ret; D011799:Quinazolines
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D051096:Proto-Oncogene Proteins c-ret; C099282:RET protein, human